drug development
-
MedCity Pivot Podcast: Tackling Rare Disease With Someone Who Was Touched By It
Rich Horgan believes that there’s an alternative path to drug development that can lower costs and the time it takes to bring drugs to market. He is trying to apply it to the field of rare and ultra-rare diseases.
-
Orphan Drug Development Is Next for Tech to Tackle
Drug developers need policies and technological infrastructure to execute on their goal of being patient-focused. At a minimum, this means a compliant way to engage patients and truly hear their voices; at its most effective, patient engagement also meets patients where they are – whenever and wherever that may be.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Danaher Continues M&A Streak, Buying Life Sciences Firm Abcam for $5.7B
Abcam’s acquisition comes two months after its board announced the exploration of strategic alternatives that could include the sale of the company. Danaher beat out at least 20 companies that were potential buyers of the life sciences tools and antibody development firm.
-
4 Ways Biopharma Is Applying AI/ML to Improve Drug Development Outcomes
Biopharma companies are harnessing AI tools for multiple aspects of drug development such as identifying drug development targets, modeling a drug’s effect on the body, and more.
-
MedCity Influencers, BioPharma
How Risk-Based Quality Management Improves Data Quality, Patient Safety, Accelerating Drug Development
Risk-based quality management, or RBQM, is the process by which pharmaceutical organizations monitor and manage quality throughout clinical trials.
-
From JPM Week: Trends That Life Science Experts Are Watching in 2023
Boston Consulting Group hosted a panel during the annual J.P. Morgan Healthcare Conference in which Merck’c chief strategy officer, a healthcare leader from Goldman Sachs, an investment executive and a senior medical devices executive from Medtronic weighed in on trends the life sciences industry can expect to see in 2023.
-
MedCity Influencers, Devices & Diagnostics, BioPharma
What Will the Pharma Industry Face in the Year Ahead?
Many pharma and medical device companies will look inward, with the goal of standardizing and modernizing even highly regulated activities. Here’s a closer look at some important industry trends for 2023.
-
MedCity Influencers, BioPharma, Legal
By Eliminating Requirement for Animal Testing, FDA Modernization Act Allows Faster, More Cost-effective Drug Development
By easing regulatory requirements for animal testing, the Act allows scientists to use innovative, leading-edge technologies more fully in future drug development strategies.
-
MedCity Influencers, BioPharma
Machine learning: An essential tool in the shift to risk-based quality management
Risk-based quality management is a data monitoring approach that accelerates the drug development pathway without compromising on safety – and one that is enhanced by the use of technologies such as artificial intelligence.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
Corporate Innovation Hubs and Healthcare Startups: The Perfect Match
Innovation hub and startup engagement models in the life sciences can take one of a few flavors with equity investments, commercial partnerships and accelerator programs covering most of the cases.
-
The state of AI in drug discovery
The MedCity INVEST PhrmaTech virtual conference, scheduled for Tuesday, July 26, offers free registration and a compelling day of conversations exploring the convergence of the health tech and biopharma sectors.
-
MedCity Influencers, BioPharma, Health Tech
The new paradigm in drug development: Why platform technology is the solution patients and payers need
The model of investing huge amounts of money into one drug to try to recoup it later is problematic at best and unsustainable at worst. Platform technology provides a better, more cost-effective way forward.
-
MedCity Influencers, Pharma, Artificial Intelligence, Health Tech
How is AI moving the needle in the pharmaceutical industry?
Artificial intelligence can help drug study teams solve operational, scientific and ethical challenges. For example, AI can be used to flag real-time trends emerging in drug trials that might otherwise not be obvious until the end of a study when all the data is analyzed.
-
MedCity Influencers, BioPharma
Behind the scenes: The role data plays in getting new therapeutics to market
In a competitive market, data that help companies find these critical resources can accelerate clinical trials and shorten time to market – sometimes by years.
-
Remote service: The new paradigm for biopharma manufacturing
Microsoft seeks to change the way pharma industry companies use technology to navigate human resource challenges and restore confidence in drug development supply chains.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
